Studies have shown that the increased expression of genes related to FAs metabolism, oxidative stress and ATP production in CRC CD8+ TIL of diabetes patients may inhibit the function of CD8+ T cells [98]. This evidence concerns the gene CD8A and colorectal carcinoma.